ProTgen

ProTgen is a biotechnology company pioneering targeted Notch activators to reactivate the thymus and reconstitute the adaptive immune system, developing the personalized progenitor T cell therapy ProT-096 for patients with refractory hematologic malignancies, in partnership with Cellares for automated manufacturing.

Company Facts

• Headquarters: Toronto, Canada
• Type: startup
• Industries: Biotechnology, Cell Therapy, Immunology